SB
NVO

Suntrust Banks’s Novo Nordisk NVO Stock Holding History

Suntrust Banks’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.41M Sell
325,460
-38,188
-11% -$966K 0.04% 270
2019
Q2 		$9.28M Sell
363,648
-13,404
-4% -$331K 0.05% 251
2019
Q1 		$9.86M Buy
377,052
+35,474
+10% +$872K 0.05% 236
2018
Q4 		$7.87M Buy
341,578
+109,784
+47% +$2.44M 0.05% 244
2018
Q3 		$5.46M Sell
231,794
-13,696
-6% -$334K 0.03% 304
2018
Q2 		$5.66M Buy
245,490
+58,724
+31% +$1.4M 0.03% 296
2018
Q1 		$4.6M Buy
186,766
+127,806
+217% +$3.36M 0.03% 321
2017
Q4 		$1.58M Buy
58,960
+1,414
+2% +$36K 0.01% 588
2017
Q3 		$1.39M Buy
57,546
+11,960
+26% +$270K 0.01% 643
2017
Q2 		$977K Buy
45,586
+13,974
+44% +$282K 0.01% 663
2017
Q1 		$541K Sell
31,612
-2,678
-8% -$46.6K ﹤0.01% 815
2016
Q4 		$613K Sell
34,290
-17,364
-34% -$315K ﹤0.01% 921
2016
Q3 		$1.07M Sell
51,654
-149,276
-74% -$3.7M 0.01% 730
2016
Q2 		$5.4M Sell
200,930
-7,566
-4% -$207K 0.03% 263
2016
Q1 		$5.65M Sell
208,496
-19,964
-9% -$535K 0.04% 252
2015
Q4 		$6.63M Sell
228,460
-5,682
-2% -$157K 0.04% 231
2015
Q3 		$6.35M Buy
234,142
+23,904
+11% +$677K 0.04% 228
2015
Q2 		$5.76M Sell
210,238
-5,300
-2% -$149K 0.04% 244
2015
Q1 		$5.75M Buy
215,538
+7,814
+4% +$180K 0.04% 241
2014
Q4 		$4.39M Sell
207,724
-11,100
-5% -$248K 0.03% 262
2014
Q3 		$5.21M Sell
218,824
-15,742
-7% -$362K 0.04% 252
2014
Q2 		$5.42M Buy
234,566
+5,034
+2% +$111K 0.04% 257
2014
Q1 		$5.24M Buy
229,532
+4,092
+2% +$87.2K 0.02% 444
2013
Q4 		$4.16M Buy
225,440
+3,930
+2% +$68.5K 0.02% 488
2013
Q3 		$3.75M Buy
221,510
+3,560
+2% +$59.9K 0.01% 496
2013
Q2 		$3.38M Buy
+217,950
New +$3.63M 0.01% 488

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Suntrust Banks's NVO Position: Q3 2019 in Review

Suntrust Banks reduced its Novo Nordisk (NVO) stake by 11% in Q3 2019, selling an estimated $966K and leaving 325,460 shares worth $8.41M. The position accounts for 0.04% of the portfolio, ranked #270.

Suntrust Banks first reported a position in NVO in Q2 2013 and has held it in 26 quarters since. The position peaked at $9.86M in Q1 2019. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • Suntrust Banks held 325,460 shares of Novo Nordisk worth $8.41M as of Q3 2019.
  • Suntrust Banks sold 38,188 Novo Nordisk shares in Q3 2019, an estimated $966K.
  • Novo Nordisk made up 0.04% of Suntrust Banks's portfolio in Q3 2019, its #270 holding.
  • Suntrust Banks first reported a position in Novo Nordisk in Q2 2013 and has held it in 26 quarters since.
  • Suntrust Banks's Novo Nordisk position peaked at $9.86M in Q1 2019.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.